Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications

Overview

Journal Nanomaterials (Basel)

Date 2021 Sep 28

PMID 34578765

Citations 16

Authors

Atiya Fatima

Md Wasi Ahmad

Abdullah Khamis Ali Al Saidi

Arup Choudhury

Yongmin Chang

Gang Ho Lee

Affiliations

Soon will be listed here.

Abstract

Gadolinium (Gd) based contrast agents (CAs) (Gd-CAs) represent one of the most advanced developments in the application of Gd for magnetic resonance imaging (MRI). Current challenges with existing CAs generated an urgent requirement to develop multimodal CAs with good biocompatibility, low toxicity, and prolonged circulation time. This review discussed the Gd-CAs used in bioimaging applications, addressing their advantages and limitations. Future research is required to establish the safety, efficacy and theragnostic capabilities of Gd-CAs. Nevertheless, these Gd-CAs offer extraordinary potential as imaging CAs and promise to benefit bioimaging applications significantly.

Citing Articles

Electrochemical Method for the Design of New Possible Gadolinium-Based Contrast Agents.

Carbone C, Stoeckle A, Minardi M, Uggeri F, Lattuada L, Minguzzi A Nanomaterials (Basel). 2024; 14(24).

PMID: 39728515 PMC: 11679725. DOI: 10.3390/nano14241979.

Composite Contrast Enhancement of Hydrogel-Based Implants for Photon-Counting Computed Tomography Studies.

Suslova E, Shashurin D, Maslakov K, Kupreenko S, Luneva T, Medvedev O Gels. 2024; 10(12).

PMID: 39727565 PMC: 11675360. DOI: 10.3390/gels10120807.

Manganese Oxide Nanoparticles for MRI-Based Multimodal Imaging and Theranostics.

Geraldes C Molecules. 2024; 29(23.

PMID: 39683750 PMC: 11643175. DOI: 10.3390/molecules29235591.

Nanocomposite based on GdO nanoparticles and drug 5-fluorouracil as potential theranostic nano-cargo system.

Szucsova J, Zelenakova A, Benova E, Nagy L, Orendac M, Huntosova V Heliyon. 2023; 9(11):e20975.

PMID: 37928043 PMC: 10623176. DOI: 10.1016/j.heliyon.2023.e20975.

Current Overview of Metal Nanoparticles' Synthesis, Characterization, and Biomedical Applications, with a Focus on Silver and Gold Nanoparticles.

Burlec A, Corciova A, Boev M, Batir-Marin D, Mircea C, Cioanca O Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895881 PMC: 10610223. DOI: 10.3390/ph16101410.

References

Engstrom M, Klasson A, Pedersen H, Vahlberg C, Kall P, Uvdal K . High proton relaxivity for gadolinium oxide nanoparticles. MAGMA. 2006; 19(4):180-6. DOI: 10.1007/s10334-006-0039-x. View

Martinelli J, Fekete M, Tei L, Botta M . Cleavable β-cyclodextrin nanocapsules incorporating Gd(III)-chelates as bioresponsive MRI probes. Chem Commun (Camb). 2011; 47(11):3144-6. DOI: 10.1039/c0cc05428c. View

Zhang W, Chen Y, Guo D, Huang Z, Cai L, He L . The synthesis of a D-glucosamine contrast agent, Gd-DTPA-DG, and its application in cancer molecular imaging with MRI. Eur J Radiol. 2010; 79(3):369-74. DOI: 10.1016/j.ejrad.2010.10.021. View

Grebenik E, Nadort A, Generalova A, Nechaev A, Sreenivasan V, Khaydukov E . Feasibility study of the optical imaging of a breast cancer lesion labeled with upconversion nanoparticle biocomplexes. J Biomed Opt. 2013; 18(7):76004. DOI: 10.1117/1.JBO.18.7.076004. View

Aime S, Barge A, Cabella C, Geninatti Crich S, Gianolio E . Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates. Curr Pharm Biotechnol. 2004; 5(6):509-18. DOI: 10.2174/1389201043376580. View

Kim S, Xu W, Ahmad M, Baeck J, Chang Y, Bae J . Synthesis of nanoparticle CT contrast agents: and studies. Sci Technol Adv Mater. 2016; 16(5):055003. PMC: 5070024. DOI: 10.1088/1468-6996/16/5/055003. View

Kang M, Lee G, Jung K, Jung J, Kim H, Kim Y . Gadolinium Nanoparticles Conjugated with Therapeutic Bifunctional Chelate as a Potential T1 Theranostic Magnetic Resonance Imaging Agent. J Biomed Nanotechnol. 2016; 12(5):894-908. DOI: 10.1166/jbn.2016.2238. View

Kim C, Baeck J, Chang Y, Bae J, Chae K, Lee G . Ligand-size dependent water proton relaxivities in ultrasmall gadolinium oxide nanoparticles and in vivo T1 MR images in a 1.5 T MR field. Phys Chem Chem Phys. 2014; 16(37):19866-73. DOI: 10.1039/c4cp01946f. View

Seo M, Gorelikov I, Williams R, Matsuura N . Microfluidic assembly of monodisperse, nanoparticle-incorporated perfluorocarbon microbubbles for medical imaging and therapy. Langmuir. 2010; 26(17):13855-60. DOI: 10.1021/la102272d. View

10.

Frias J, Williams K, Fisher E, Fayad Z . Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. J Am Chem Soc. 2004; 126(50):16316-7. DOI: 10.1021/ja044911a. View

11.

Liu Y, Chen Z, Liu C, Yu D, Lu Z, Zhang N . Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer. Biomaterials. 2011; 32(22):5167-76. DOI: 10.1016/j.biomaterials.2011.03.077. View

12.

Hu X, Tang Y, Hu Y, Lu F, Lu X, Wang Y . Gadolinium-Chelated Conjugated Polymer-Based Nanotheranostics for Photoacoustic/Magnetic Resonance/NIR-II Fluorescence Imaging-Guided Cancer Photothermal Therapy. Theranostics. 2019; 9(14):4168-4181. PMC: 6592180. DOI: 10.7150/thno.34390. View

13.

Yang Z, He W, Zheng H, Wei J, Liu P, Zhu W . One-pot synthesis of albumin-gadolinium stabilized polypyrrole nanotheranostic agent for magnetic resonance imaging guided photothermal therapy. Biomaterials. 2018; 161:1-10. DOI: 10.1016/j.biomaterials.2018.01.026. View

14.

Scott R, Quaggin S . Review series: The cell biology of renal filtration. J Cell Biol. 2015; 209(2):199-210. PMC: 4411276. DOI: 10.1083/jcb.201410017. View

15.

Ahmad M, Ahmad M, Yue H, Ho S, Park J, Jung K . In Vivo Positive Magnetic Resonance Imaging Applications of Poly(methyl vinyl ether-alt-maleic acid)-coated Ultra-small Paramagnetic Gadolinium Oxide Nanoparticles. Molecules. 2020; 25(5). PMC: 7179159. DOI: 10.3390/molecules25051159. View

16.

Ghaghada K, Starosolski Z, Bhayana S, Stupin I, Patel C, Bhavane R . Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta. Placenta. 2017; 57:60-70. DOI: 10.1016/j.placenta.2017.06.008. View

17.

Huang C, Huang C, Mai F, Yen C, Tzing S, Hsieh H . Application of paramagnetic graphene quantum dots as a platform for simultaneous dual-modality bioimaging and tumor-targeted drug delivery. J Mater Chem B. 2020; 3(4):651-664. DOI: 10.1039/c4tb01650e. View

18.

Mulder W, Strijkers G, Griffioen A, van Bloois L, Molema G, Storm G . A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjug Chem. 2004; 15(4):799-806. DOI: 10.1021/bc049949r. View

19.

Petrik M, Weigel C, Kirsch M, Hosten N . [No detectable nephrotoxic side effect using a dimer, non-ionic contrast media in cerebral perfusion computed tomography in case of suspected brain ischemia]. Rofo. 2005; 177(9):1242-9. DOI: 10.1055/s-2005-858318. View

20.

Shiraishi K, Kawano K, Maitani Y, Yokoyama M . Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics. J Control Release. 2010; 148(2):160-7. DOI: 10.1016/j.jconrel.2010.08.018. View